نتائج البحث - "Sophia Pathai"

المصدر: Suhler, E B, Jaffe, G J, Fortin, E, Lim, L L, Merrill, P T, Dick, A D, Brezin, A P, Nguyen, Q D, Thorne, J E, Van Calster, J, Cimino, L, Adan, A, Goto, H, Kaburaki, T, Kramer, M, Vitale, A T, Kron, M, Song, A P, Liu, J, Pathai, S, Douglas, K M, Schlaen, A, Muccioli, C, Van Velthoven, M E J, Zierhut, M & Rosenbaum, J T 2020, ' Long-Term Safety and Efficacy of Adalimumab in Patients With Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis ', Ophthalmology . https://doi.org/10.1016/j.ophtha.2020.10.036

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Time Factors, Visual acuity, Injections, Subcutaneous, Anti-Inflammatory Agents, Visual Acuity, Young Adult, 03 medical and health sciences, 0302 clinical medicine, adalimumab, Internal medicine, Panuveitis, medicine, Adalimumab, Humans, In patient, Adverse effect, Macular edema, Aged, Retrospective Studies, 030304 developmental biology, Aged, 80 and over, 0303 health sciences, Dose-Response Relationship, Drug, business.industry, Uveitis, Posterior, Middle Aged, medicine.disease, Ophthalmology, Treatment Outcome, uveitis, 030221 ophthalmology & optometry, Intermediate uveitis, Female, Noninfectious uveitis, treatment-emergent adverse event, Uveitis, medicine.symptom, business, Uveitis, Intermediate, Follow-Up Studies, medicine.drug

وصف الملف: application/pdf; Print-Electronic

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b2a6cc50379aad1f3fbd039786fe4f0
https://doi.org/10.1016/j.ophtha.2020.10.036

View record from ScienceDirect

Full Text via ClinicalKey

6

New observations and emerging ideas in diagnosis and management of non-infectious uveitis: A review

المؤلفون: Mei Ling Tay-Kearney, K. Douglas, C. Stephen Foster, Martina Kron, Carlos Pavesio, Alexandra P. Song, Piergiorgio Neri, Manfred Zierhut, Bahram Bodaghi, Sophia Pathai, James T. Rosenbaum, Nisha R. Acharya, Cristobal Couto

المصدر: Seminars in Arthritis and Rheumatism. 49:438-445

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd141e086e9d5215b755d03876037cad
https://doi.org/10.1016/j.semarthrit.2019.06.004

View record from ScienceDirect

Full Text via ClinicalKey

7

OP0086 Long-term efficacy and safety of adalimumab by immunosuppressant use in patients with non-infectious uveitis in the visual iii trial

المؤلفون: Hiroshi Goto, K. Douglas, Alfredo Adán, Martina Kron, C.S. Foster, Yan Guex-Crosier, Alexandra P. Song, Kei Nakai, J Van Calster, Sophia Pathai

المصدر: WEDNESDAY, 13 JUNE 2018.

مصطلحات موضوعية: medicine.medical_specialty, Vitreous haze, business.industry, Continuous variable, Infectious uveitis, Internal medicine, Concomitant, medicine, Adalimumab, Dose reduction, In patient, business, Adverse effect, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::993fa4dd0a9b83af0c373e09bdf3f7e0
https://doi.org/10.1136/annrheumdis-2018-eular.2551

8

Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III

المصدر: Suhler, E B, Adán, A, Brézin, A P, Fortin, E, Goto, H, Jaffe, G J, Kaburaki, T, Kramer, M, Lim, L L, Muccioli, C, Nguyen, Q D, Van Calster, J, Cimino, L, Kron, M, Song, A P, Liu, J, Pathai, S, Camez, A, Schlaen, A, van Velthoven, M E J, Vitale, A T, Zierhut, M, Tari, S & Dick, A D 2018, ' Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study : VISUAL III ', Ophthalmology, vol. 125, no. 7, pp. 1075-1087 . https://doi.org/10.1016/j.ophtha.2017.12.039

مصطلحات موضوعية: Male, Visual acuity, MULTICENTER, Anti-Inflammatory Agents, Visual Acuity, law.invention, INTERMEDIATE UVEITIS, 0302 clinical medicine, Randomized controlled trial, law, Panuveitis, REFRACTORY UVEITIS, RISK, Aged, 80 and over, Middle Aged, PREVALENCE, Treatment Outcome, POSTERIOR UVEITIS, Intermediate uveitis, Corticosteroid, Female, medicine.symptom, Life Sciences & Biomedicine, Uveitis, Intermediate, Uveitis, medicine.drug, Adult, medicine.medical_specialty, medicine.drug_class, PANUVEITIS, 03 medical and health sciences, Young Adult, Double-Blind Method, Ophthalmology, MANAGEMENT, medicine, Adalimumab, Humans, Adverse effect, Aged, 030203 arthritis & rheumatology, Science & Technology, Intention-to-treat analysis, business.industry, Uveitis, Posterior, STANDARDIZATION, medicine.disease, 030221 ophthalmology & optometry, business, Follow-Up Studies